NUCB2 and breast carcinoma: Our results showed that the average concentration of Nesfatin-1 in breast cancer patients was significantly higher than that in healthy controls (P < 0.01, Fig. 1C), which was consistent with the high expression of NUCB2 in breast cancer tissues.